Morgan Stanley raised the price target for the Pfizer Inc. (NYSE:PFE) stock to "an Equal-weight". The rating was released on April 06, 2022, according...
Morgan Stanley raised the price target for the Pfizer Inc. (NYSE:PFE) stock to "an Equal-weight". The rating was released on April 06, 2022, according...
Pfizer (PFE) and BioNTech (BNTX) plan to produce 2 billion doses of the coronavirus vaccine this year, instead of 1.3 billion doses initially planned,...
On Monday stocks of several vaccine makers remained buoying in different direction. Pfizer Inc (PFE) was down -4.6% to $39.12 and BioNTech SE (BNTX)...
The United States' primary stock indices ended the trading session in positive territory on Tuesday, December 1, with expectations that mass deliveries of the...
The U.S. and German Biotech’s are aiming to obtain the clearance for their potential coronavirus vaccine. The EU authorization will allow Pfizer-BioNTech to supply...
Despite the confirmation of the very high efficacy of Pfizer/BioNTech and Moderna vaccine candidates in recent days, investors know that the economy is likely...